Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI
St. Jude Medical announced primary outcome two-year data from the FAME 2 Trial which demonstrated sustained superiority with FFR-guided PCI using St. Jude Medical PressureWireTM technology in patients with stable coronary artery disease compared to standard medical therapy alone. September 02, 2014